Cargando…

Assessment of a cancer genomic profile test for patients with metastatic breast cancer

Comprehensive cancer genomic profile (CGP) tests are being implemented under Japanese universal health insurance system. However, the clinical usefulness of CGP test for breast cancer patients has not been evaluated. Of the 310 patients who underwent CGP testing at our institution between November 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukada, Ippei, Mori, Seiichi, Hayashi, Naomi, Hosonaga, Mari, Yamazaki, Masumi, Wang, Xiaofei, Kawai, Saori, Inagaki, Lina, Ozaki, Yukinori, Kobayashi, Kokoro, Hara, Fumikata, Kobayashi, Takayuki, Ueki, Arisa, Osako, Tomo, Tonooka, Akiko, Takeuchi, Kengo, Ueno, Takayuki, Takano, Toshimi, Ohno, Shinji, Takahashi, Shunji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938506/ https://www.ncbi.nlm.nih.gov/pubmed/35315838 http://dx.doi.org/10.1038/s41598-022-08925-3

Ejemplares similares

MO33-7 Preparedness for COVID-19 pandemic and impact on medical oncology for breast cancer
por: Inagaki, Lina, et al.
Publicado: (2021)

Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study
por: Ozaki, Yukinori, et al.
Publicado: (2022)

Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer
por: Chin, Yoon Ming, et al.
Publicado: (2022)

Druggable gene alterations in Japanese patients with rare malignancy
por: Ohmoto, Akihiro, et al.
Publicado: (2022)

Evaluation of an inflammation-based score for identification of appropriate patients for comprehensive genomic profiling
por: Hayashi, Naomi, et al.
Publicado: (2022)

The impact of obesity and endocrine therapy on the prognosis of premenopausal women with hormone receptor‐positive breast cancer: A single‐institute retrospective study
por: Ozaki, Yukinori, et al.
Publicado: (2022)

Imatinib could be a new strategy for pulmonary hypertension caused by pulmonary tumor thrombotic microangiopathy in metastatic breast cancer
por: Fukada, Ippei, et al.
Publicado: (2016)

The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel
por: Fukada, Ippei, et al.
Publicado: (2017)

Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer
por: Inoue, Yuka, et al.
Publicado: (2022)

Combination chemotherapy with mitomycin C and methotrexate is active against metastatic HER2-negative breast cancer even after treatment with anthracycline, taxane, capecitabine, and vinorelbine
por: Fukuda, Takayo, et al.
Publicado: (2015)

Eribulin-induced liver dysfunction as a prognostic indicator of survival of metastatic breast cancer patients: a retrospective study
por: Kobayashi, Takayuki, et al.
Publicado: (2016)

Utility of Preoperative Computed Tomography Scans for Coronavirus Disease in a Cancer Treatment Center
por: Ozaki, Yukinori, et al.
Publicado: (2021)

Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin
por: Saeki, Sumito, et al.
Publicado: (2023)

Cystoid Macular Edema during Treatment with Paclitaxel and Bevacizumab in a Patient with Metastatic Breast Cancer: A Case Report and Literature Review
por: Yokoe, Takamichi, et al.
Publicado: (2017)

Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer
por: Fukada, Ippei, et al.
Publicado: (2016)

A Case of Recurrent Breast Cancer Identified by Pulmonary Tumor Thrombotic Microangiopathy
por: Abe, Tomomi, et al.
Publicado: (2017)

Mitigation of paclitaxel-induced peripheral neuropathy in breast cancer patients using limb-cooling apparatus: a study protocol for a randomized controlled trial
por: Funasaka, Chikako, et al.
Publicado: (2023)

Decreased hormonal sensitivity after childbirth rather than the tumor size influences the prognosis of very young breast cancer patients
por: Makita, Masujiro, et al.
Publicado: (2015)

Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel
por: Araki, Kazuhiro, et al.
Publicado: (2018)

Assessment of axillary node status by ultrasound after neoadjuvant chemotherapy in patients with clinically node-positive breast cancer according to breast cancer subtype
por: Maeshima, Yurina, et al.
Publicado: (2021)

GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer
por: Kumegawa, Kohei, et al.
Publicado: (2022)

The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor‐positive breast cancer
por: Fukuoka, Megumi, et al.
Publicado: (2022)

Implementation of microsatellite instability testing for the assessment of solid tumors in clinical practice
por: Nakayama, Izuma, et al.
Publicado: (2022)

Chromatin conformational changes at human satellite II contribute to the senescence phenotype in the tumor microenvironment
por: Miyata, Kenichi, et al.
Publicado: (2023)

Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer: a case report
por: Maeshima, Yurina, et al.
Publicado: (2021)

Detection of BRCA1 Pathogenic Variant in a 24-Year-Old Endometrial Cancer Patient: Risks of Several Hereditary Tumor Syndromes Assessed Using Germline Multigene Panel Testing
por: Wang, Xiaofei, et al.
Publicado: (2022)

Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility
por: Kumegawa, Kohei, et al.
Publicado: (2023)

Correction: Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility
por: Kumegawa, Kohei, et al.
Publicado: (2023)

Pathogenicity assessment of variants for breast cancer susceptibility genes based on BRCAness of tumor sample
por: Yoshida, Reiko, et al.
Publicado: (2021)

Professional Caregiver's View on Mental Health in Parents of Children with Developmental Disabilities: A Nationwide Study of Institutions and Consultation Centers in Japan
por: Kobayashi, Tomoka, et al.
Publicado: (2012)

Effectiveness of self-help workbook intervention on quality of life in cancer patients receiving chemotherapy: results of a randomized controlled trial
por: Takano, Toshimi, et al.
Publicado: (2021)

Influence of menopause on chemotherapy‐induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study
por: Yokokawa, Takashi, et al.
Publicado: (2023)

The origin of the frequency selectivity in VOR motor learning revealed by a realistic cerebellar spiking neuron network model.
por: Inagaki, Keiichiro, et al.
Publicado: (2010)

Efficacy and safety of pegfilgrastim biosimilar MD‐110 in patients with breast cancer receiving chemotherapy: Single‐arm phase III
por: Takano, Toshimi, et al.
Publicado: (2023)

Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study
por: Ozaki, Yukinori, et al.
Publicado: (2018)

Lack of PTEN in osteocytes increases circulating phosphate concentrations by decreasing intact fibroblast growth factor 23 levels
por: Kawai, Masanobu, et al.
Publicado: (2020)

Pertuzumab retreatment for HER2‐positive advanced breast cancer: A randomized, open‐label phase III study (PRECIOUS)
por: Yamamoto, Yutaka, et al.
Publicado: (2022)

Ewing sarcoma of the liver with multilocular cystic mass formation: a case report
por: Ozaki, Yukinori, et al.
Publicado: (2015)

Changes in CT morphology can be an independent response marker for patients receiving regorafenib for colorectal liver metastases: retrospective pilot study
por: Ozaki, Yukinori, et al.
Publicado: (2018)

Pharmacoeconomic analysis of biologics and methotrexate for rheumatoid arthritis from the standpoint of the number needed to treat concept under the Japanese health insurance system
por: Harigane, Kengo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_prmpfa3ndv8nfklup0vd1keov0